Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis

[1] Katznelson L(2014)Acromegaly: an endocrine society clinical practice guideline J Clin Endocrinol Metab 99 3933-3951

[2] Laws ER(2017)Acromegaly: clinical features at diagnosis Pituitary 20 22-32

[3] Melmed S(2011)High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly Eur J Endocrinol 164 475-483

[4] Molitch ME(2008)Prevalence of vertebral fractures in men with acromegaly J Clin Endocrinol Metab 93 4649-4655

[5] Murad MH(2008)Growth hormone, insulin-like growth factors, and the skeleton Endocr Rev 29 535-559

[6] Utz A(2007)In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender Neuroendocrinol Lett 28 621-628

[7] Vilar L(2019)Diagnosis of endocrine disease: evaluation of bone fragility in endocrine disorders Eur J Endocrinol 180 R213-R232

[8] Vilar CF(2001)Bone metabolism and body composition in Japanese patients with active acromegaly Clin Endocrinol (Oxf) 55 175-181

[9] Lyra R(2020)Acromegaly and vertebral fractures: facts and questions Trends Endocrinol Metab 31 274-275

[10] Lyra R(2018)Pituitary diseases and bone Endocr Rev 39 440-488

[1] Katznelson L(2014)Acromegaly: an endocrine society clinical practice guideline J Clin Endocrinol Metab 99 3933-3951

[2] Laws ER(2017)Acromegaly: clinical features at diagnosis Pituitary 20 22-32

[3] Melmed S(2011)High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly Eur J Endocrinol 164 475-483

[4] Molitch ME(2008)Prevalence of vertebral fractures in men with acromegaly J Clin Endocrinol Metab 93 4649-4655

[5] Murad MH(2008)Growth hormone, insulin-like growth factors, and the skeleton Endocr Rev 29 535-559

[6] Utz A(2007)In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender Neuroendocrinol Lett 28 621-628

[7] Vilar L(2019)Diagnosis of endocrine disease: evaluation of bone fragility in endocrine disorders Eur J Endocrinol 180 R213-R232

[8] Vilar CF(2001)Bone metabolism and body composition in Japanese patients with active acromegaly Clin Endocrinol (Oxf) 55 175-181

[9] Lyra R(2020)Acromegaly and vertebral fractures: facts and questions Trends Endocrinol Metab 31 274-275

[10] Lyra R(2018)Pituitary diseases and bone Endocr Rev 39 440-488